文章名稱引用次數

• COPDGene (R) 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease18
• National and State Estimates of COPD Morbidity and Mortality United States, 2014-201515
• Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials13
• The Role of Inhalation Delivery Devices in COPD: Perspectives o Patients and Health Care Providers9
• Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene (R) Cohort8
• The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia-Results from the U.S. Bronchiectasis Research Registry7
• Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease7
• New Therapeutic Targets for Alpha-1 Antitrypsin Deficiency6
• Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality6
• Pulmonary Subtypes Exhibit Differential Global Initiative for Chronic Obstructive Lung Disease Spirometry Stage Progression: The COPDGene (R) Study6